BSEClinitech Laboratory LtdMinimalNeutral
Announced Tue, 7 Apr · 18:16 IST

RTA certifies no rematerialisation requests in Q4 FY26

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Clinitech Laboratory's Registrar and Transfer Agent, Bigshare Services Pvt. Ltd., has filed a certificate under SEBI Regulation 74(5) of the Depositories and Participants Regulations, 2018, for the quarter ended March 31, 2026. The certificate confirms that the company received no requests from any members for rematerialisation of shares during the quarter. This is a routine compliance disclosure confirming all shares remain in dematerialised form. Filed by Chairman and MD Jagdish Umakant Nayak.

Likely market impact

Routine regulatory compliance filing with no material impact on shareholders or stock price.